GliaSite RTS Information Request
Common Questions

Why may the GliaSite Radiation Therapy System (RTS) help in brain cancer treatment?
Studies have shown that radiation therapy after tumor removal surgery extends survival in patients with malignant brain tumors. The GliaSite RTS delivers radiation therapy from the inside. This places the radiation closest to the tissue most likely to still have cancer cells. It also reduces radiation exposure to healthy brain tissue.

How will this treatment affect healthy brain tissue?
By placing the GliaSite RTS inside the brain, radiation travels from the inside of the tumor resection cavity out to targeted tissue. This minimizes radiation exposure to healthy brain tissue.

Are there any known complications and/or side effects?
In clinical trials, complications were comparable to those of other brain cancer treatments. Common side effects included headache, constipation, insomnia and nausea.

How long does radiation treatment last?
Typically radiation treatment lasts anywhere between 3 to 7 days, depending on your course of treatment.

Will I be in the hospital during treatment?
Outpatient delivery of radiation is feasible and available at some facilities. Ask your doctor if outpatient treatment is an option for you.

What can I expect to experience during my radiation treatment?
Patients typically experience little to no discomfort during radiation treatment. Most patients read books, watch TV, and carry out their activities of daily living.

What if the fluid leaks out of the balloon while implanted?
During treatment, the GliaSite balloon catheter is inflated with saline (salt water) and Iotrex® Radiotherapy Solution, a liquid radiation source. For additional safety, there is actually a second balloon that envelopes the balloon containing the Iotrex Radiotherapy Solution. In the unlikely event that a leak occurs through both balloons, the fluid will be flushed quickly out of your body. Iotrex Radiotherapy Solution was designed to be quickly eliminated through the urine. Studies have verified the rapid urinary clearance without radiation effects to other organs.

Will this treatment limit my ability to receive other types of treatments in the future?
The GliaSite RTS delivers radiation therapy from the inside, placing the radiation close to the tissue most likely to still have cancer cells. Many factors will influence whether additional therapy is possible, but therapy with the GliaSite RTS does not exclude the use of radiation therapy in the future. Other treatments, such as chemotherapy, may also be prescribed.

Will treatment with the GliaSite RTS be reimbursed by my insurer?
Radiation delivery via brachytherapy is a longstanding accepted treatment for malignant brain tumors and has been paid for many years. However, coverage of the GliaSite RTS will depend on your individual healthcare plan.

How do I find out where the GliaSite RTS is available?
To find out what hospitals are licensed to provide the GliaSite therapy, please use our treatment center locator or contact Cytyc Surgical Products Customer Service at 1-800-442-9892.

Note: If you are reviewing this Web site in relation to a condition or ailment from which you suffer or may suffer, you should seek the advice of a physician. If you are reviewing this Web site in relation to a condition or ailment from which a family member or dependent suffers, you should urge that person to seek the advice of a physician.

GliaSite Common Questions
Quick Facts
arrow This site provides important information about current therapies for brain cancer, including the GliaSite RTS. This information is, however, intended only as a guide. If you have additional questions, your doctor is always your best source of information.
Hologic Home Page
© 2005-2008 Cytyc. A Hologic Company. All Rights Reserved